Related Experiment Video
Updated: Jun 12, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Analysis of beta-defensin and Toll-like receptor gene copy number variation in celiac disease
Nora Fernandez-Jimenez1, Ainara Castellanos-Rubio, Leticia Plaza-Izurieta
1Endocrinology, Diabetes and Nutrition Research Group, Hospital de Cruces, Barakaldo-Bizkaia, Basque Country, Spain.
Abstract:
Celiac disease (CD) is an immune-mediated disorder of the gut in which innate and adaptive responses are involved. Toll-like receptor (TLR) 2 and TLR4 participate in host defense through antigen recognition, and show altered expression in CD gut mucosa. beta-defensins are inducible antimicrobial peptides, and DEFB gene copy number polymorphisms have been associated with autoimmune and inflammatory disorders. We performed copy number analysis of TLR2, TLR4, and the beta-defensin cluster (DEFB4, DEFB103 and DEFB104) by gene-specific, real-time polymerase chain reaction (PCR) in 376 CD patients and 376 controls. TLR genes did not show copy number variation, and all samples presented with two copies. beta-defensin clusters varied between 2 and 9 copies per genome, and when grouped into bins, high copy numbers (>4) were underrepresented among patients (p = 0.023; odds ratio = 0.69, 95% CI = 0.50-0.96), suggesting that increased copy numbers could protect from CD, possibly by impeding bacterial infiltration more efficiently and preserving gut epithelial integrity.
Insights
Higher copy numbers of beta-defensin genes may protect against celiac disease (CD). This finding suggests a potential genetic factor influencing the immune-mediated gut disorder, impacting host defense mechanisms.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Celiac disease (CD) is an immune-mediated gut disorder involving innate and adaptive immune responses.
- Toll-like receptors (TLRs) 2 and 4 are involved in antigen recognition and show altered expression in CD.
- Beta-defensins are antimicrobial peptides, and their gene copy number variations are linked to inflammatory conditions.
Purpose of the Study:
- To investigate the association between copy number variations of Toll-like receptor (TLR) genes (TLR2, TLR4) and beta-defensin clusters (DEFB4, DEFB103, DEFB104) and celiac disease.
- To determine if gene copy number polymorphisms in these immune-related genes influence CD susceptibility.
Main Methods:
- Copy number analysis of TLR2, TLR4, and beta-defensin gene clusters was performed using gene-specific, real-time polymerase chain reaction (PCR).
- The study included 376 celiac disease patients and 376 healthy controls.
- Statistical analysis, including odds ratio and confidence intervals, was used to assess the association between gene copy numbers and CD.
Main Results:
- TLR2 and TLR4 genes exhibited no copy number variation, with all samples having two copies.
- Beta-defensin clusters displayed copy number variations ranging from 2 to 9 copies per genome.
- High copy numbers of beta-defensin clusters (>4 copies) were significantly underrepresented in celiac disease patients (p = 0.023; OR = 0.69).
Conclusions:
- Increased copy numbers of beta-defensin gene clusters may confer a protective effect against celiac disease.
- This suggests that higher beta-defensin copy numbers might enhance host defense by improving bacterial infiltration control and maintaining gut epithelial integrity.
- Gene copy number variation in beta-defensin clusters represents a potential genetic factor influencing celiac disease susceptibility.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Inflammatory Bowel Disease II: Ulcerative Colitis

